IGF1 and cancer: Although this has not been yetdemonstrated, the remarkable effects of fasting on the down-regulation of anumber of growth factors and signal transduction pathways targeted byanti-cancer drugs, including IGF-I and the TOR/S6 kinase pathways, raises the possibilitythat it could enhance the efficacy of cancer treatment drugs and may even be aseffective as some of them.